Zobrazeno 1 - 10
of 58
pro vyhledávání: '"R. Kalmeijer"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ceyhun Bicer, Maria Beumont-Mauviel, Markus Cornberg, Sivi Ouwerkerk-Mahadevan, David Back, Saye Khoo, Fiona Marra, M. Schlag, W. Jessner, Christoph Hoener zu Siederdissen, I. Lonjon-Domanec, R. Kalmeijer
Publikováno v:
British Journal of Clinical Pharmacology. 84:961-971
Aims Direct-acting antiviral agents (DAAs) for the treatment of hepatitis C (HCV) can be associated with drug-drug interactions (DDIs) with concomitant medications. The practical clinical implications of such DDIs are poorly understood. We assessed t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b8be15046ffb74acd93e39900e5c9ef
https://doi.org/10.1111/bcp.13519
https://doi.org/10.1111/bcp.13519
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jun Cheng, Sivi Ouwerkerk-Mahadevan, Qing Xie, Thierry Verbinnen, Eva Hoeben, Jia Shang, Lai Wei, James Witek, Oliver Lenz, Ju Hyun Kim, Jeong Heo, Mengchun Li, Xinyue Chen, Jane Scott, Monika Peeters, Dongliang Yang, R. Kalmeijer, Tao Han, Rekha Sinha
Publikováno v:
Journal of Gastroenterology and Hepatology. 31:912-920
Background and Aim Approximately one-third of patients with hepatitis C virus (HCV) genotype (GT) 1 infection live in East Asia. This study evaluated the efficacy, pharmacokinetics, safety, and tolerability of simeprevir plus peginterferon alpha-2a a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a9e5df29e5abfdefb1827743a3ab0e5
https://doi.org/10.1111/jgh.13288
https://doi.org/10.1111/jgh.13288
Autor:
David E. Bernstein, Bart Fevery, Paul Y. Kwo, Eugene R. Schiff, Rekha Sinha, M. Davis, Ronald Nahass, Jane Scott, Norman Gitlin, James Witek, R. Kalmeijer, Monika Peeters, Sergio Rojter, Peter Ruane, Guy De La Rosa, K.P. Etzkorn, Oliver Lenz, Ziad Younes
Publikováno v:
Hepatology (Baltimore, Md.)
Effective antiviral therapy is essential for achieving sustained virological response (SVR) in hepatitis C virus (HCV)-infected patients. The phase 2 COSMOS study reported high SVR rates in treatment-naive and prior null-responder HCV genotype (GT) 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::deadbc48ce67ec8a149e5c3c72075988
http://europepmc.org/articles/PMC5412860
http://europepmc.org/articles/PMC5412860
Autor:
Robert Herring, Aasim Sheikh, Eric M. Yoshida, Reem Ghalib, Guy De La Rosa, Hillel Tobias, Eliot Godofsky, Oliver Lenz, Monika Peeters, Gary Matusow, Rekha Sinha, Jane Scott, Bart Fevery, James Witek, Eric Lawitz, Franco Felizarta, Gary Poleynard, R. Kalmeijer, Marcelo Kugelmas, Edwin DeJesus
Publikováno v:
Hepatology (Baltimore, Md.)
UNLABELLED Hepatitis C virus (HCV)-infected patients with cirrhosis are historically a difficult-to-treat population and are at risk of hepatic decompensation. In the phase 2 COSMOS study that evaluated simeprevir (HCV NS3/4A protease inhibitor) + so
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1cc98c5801eb45ef1c93d898a7703ba
https://doi.org/10.1002/hep.28422
https://doi.org/10.1002/hep.28422
Autor:
Gavin Cloherty, James A. Hamilton, Ching-Lung Lai, Dkh Wong, Stephen Locarnini, TH Lim, A. Thompson, M. Beumont-Mauviel, Carlo Ferrari, Kathy Jackson, S Strasser, William Sievert, Robert G. Gish, W Cheng, Bruce D. Given, R. Kalmeijer, T. Schluep, Rmf Yuen, E.J. Gane, M Biermer, C Schwabe, Oliver Lenz
Publikováno v:
Journal of Hepatology. 73:S20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fdda8a4b0229cd4ee711f76afec33dd5
https://doi.org/10.1016/s0168-8278(20)30597-3
https://doi.org/10.1016/s0168-8278(20)30597-3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Bart Fevery, Edward Gane, Chris Corbett, Ewa Janczewska, Maria Beumont, Suzanne Bourgeois, Moisés Diago, R. Kalmeijer, Edwin DeJesus, Jacob George, Peter Ferenci, W. Jessner, Mariliza Hendrique Da Silva, Henk W. Reesink, Holger Hinrichsen, Oliver Lenz, Umesh Shukla, I. V. Nikitin
Publikováno v:
BMC Infectious Diseases, Vol 17, Iss 1, Pp 1-13 (2017)
BMC infectious diseases, 17(1). BioMed Central
BMC Infectious Diseases
BMC infectious diseases, 17(1). BioMed Central
BMC Infectious Diseases
Background This Phase 3, open-label, rollover study (NCT01323244) investigated the efficacy and safety of simeprevir plus peginterferon α-2a (PegIFNα-2a) and ribavirin (RBV) in a well-characterized population of HCV genotype 1 (GT1)-infected treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d80730c83607b4227a752269b3f9f1d
https://doi.org/10.1186/s12879-017-2444-3
https://doi.org/10.1186/s12879-017-2444-3
Autor:
Martina Sterneck, Zoe Mariño, Katrien Janssen, Sivi Ouwerkerk-Mahadevan, Marina Berenguer, T. Cieciura, Jose Luis Calleja, Pietro Andreone, Oliver Lenz, Xavier Forns, Magdalena Durlik, Umesh Shukla, Thierry Verbinnen, Kerstin Herzer, Stefano Fagiuoli, W. Jessner, R. Kalmeijer, Maria Francesca Donato, Monika Peeters
Publikováno v:
TRANSPLANT INFECTIOUS DISEASE
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Background Recurrent hepatitis C virus (HCV) infection following liver transplantation is associated with accelerated progression to graft failure and reduced patient survival. Methods The Phase II, open-label SATURN study (NCT01938625) investigated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb19253f90066bf5c574f69fc633c552
http://hdl.handle.net/10281/391806
http://hdl.handle.net/10281/391806
